Lmr Partners LLP Bristol Myers Squibb CO Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

A detailed history of Lmr Partners LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lmr Partners LLP holds 259,962 shares of BMY stock, worth $15 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

259,962

Holding current value

$15 Million

% of portfolio

0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$39.66 - $51.75 $10.3 Million - $13.5 Million	259,962 New	259,962 $13.5 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $335,991 - $391,687	-6,265 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $370,700 - $434,227	6,265 New	6,265 $371,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $839,437 - $914,147	-13,559 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $254,805 - $286,581	-4,294 Reduced 24.05%	13,559 $856,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $86,436 - $97,948	-1,497 Reduced 7.74%	17,853 $1.11 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $1.11 Million - $1.23 Million	19,350 New	19,350 $1.17 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $2.87 Million - $3.36 Million	-52,413 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $684,307 - $994,457	-14,748 Reduced 21.96%	52,413 $2.85 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $3.3 Million - $4.31 Million	67,161 New	67,161 $4.31 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $8.08 Million - $8.93 Million	-181,042 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $8.17 Million - $9.74 Million	181,042 New	181,042 $8.64 Million
Q4 2017 Jan 30, 2018	SELL	$59.94 - $65.35 $438,041 - $477,577	-7,308 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $403,620 - $465,811	7,308	7,308 $465,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account